JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

Cell Systems is an esteemed journal published by CELL PRESS, dedicated to advancing the field of systems biology and its applications in cell biology, histology, and pathology. Since its inception in 2015, it has quickly ascended to a prominent position within the academic community, currently holding a Q1 ranking across multiple categories including Cell Biology, Histology, and Pathology and Forensic Medicine for 2023. With an impressive Scopus ranking—third in Medicine: Pathology and Forensic Medicine, and similarly high standing in Histology—it serves as a key resource for researchers and professionals aiming to explore and disseminate cutting-edge research findings. The journal provides an open-access platform, making it an accessible source of knowledge for students and scholars alike, fostering collaboration and innovation within the dynamic landscape of cellular research. With a commitment to high-quality and impactful publications, Cell Systems plays a pivotal role in shaping the future of biological sciences.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

aBIOTECH, published by SPRINGERNATURE, is a premier academic journal dedicated to advancing the fields of biotechnology, agronomy, and molecular biology. With an impressive ISSN of 2096-6326 and E-ISSN 2662-1738, this journal has established itself as a vital resource for researchers and professionals aiming to publish high-quality, impactful studies. Based in Singapore, aBIOTECH has achieved remarkable recognition, boasting a Q1 ranking in multiple categories including Agronomy and Crop Science, Biochemistry, and Genetics in the 2023 Scopus rankings. Its solid position in the 90th percentile for Biochemistry and Genetics reinforces its significance within the global scientific community. The journal covers a broad spectrum of topics relevant to both basic and applied research, facilitating a shared dialogue amongst scientists and encouraging collaborative progress in innovative biotechnological applications. The open-access nature of the journal ensures that cutting-edge research is freely available, fostering a global exchange of ideas that is critical to the advancement of science today.

npj Systems Biology and Applications, published by NATURE PORTFOLIO, is a premier open-access journal that has been at the forefront of the field since its inception in 2015. With a commendable focus on the interdisciplinary integration of applied mathematics, biochemistry, computer science, and drug discovery, the journal currently enjoys a Q1 ranking across multiple categories, showcasing its significant impact within the scientific community. In 2023, it ranked 70 out of 635 in Applied Mathematics and holds a notable place in the 89th percentile, confirming its esteemed reputation among researchers. Situated in the United Kingdom, this journal not only promotes innovative research in systems biology but also serves as an essential platform for the dissemination of high-quality studies that delve into modeling, simulation, and the application of biological systems in drug discovery processes. With an open-access model, authors can reach a broad audience, enhancing collaborations and advancing knowledge across disciplines, making it an indispensable resource for researchers, professionals, and students alike seeking to contribute to the evolving landscape of systems biology.

Nature Biomedical Engineering is a premier journal published by NATURE PORTFOLIO, focusing on innovative research at the intersection of engineering and biomedical sciences. With an ISSN of 2157-846X, this journal aims to disseminate groundbreaking studies that advance the field of bioengineering, biotechnology, and medical applications. Since its inception in 2017, it has rapidly earned a reputation for excellence, consistently achieving a Q1 ranking in various categories including Bioengineering and Biomedical Engineering, and receiving acclaim in prestigious Scopus rankings, boasting top positions in the fields of Computer Science Applications and Medicine. The journal operates under a rigorous peer-review process, ensuring that all published articles contribute substantially to the existing body of knowledge. Furthermore, it facilitates a broad accessibility model for researchers and practitioners, bolstering collaboration and innovation within the global scientific community. Nature Biomedical Engineering is not just a publication; it serves as a vital platform for thought leadership in the transformative field of biomedical engineering.